Rare diseases
Investigational molecules
Locations
Study of Dapagliflozin for Reducing Cardiovascular Events in Adults with High Blood Pressure
AustriaStudy of beta blockers in patients with aortic stenosis undergoing transcatheter aortic valve replacement
AustriaStudy of human normal immunoglobulin and teclistamab for infection prevention in adults with multiple myeloma receiving B-cell maturation antigen therapy
AustriaStudy of plozasiran to prevent acute pancreatitis in adults with severe hypertriglyceridemia
AustriaStudy of rilzabrutinib tablets compared to placebo in adults with warm autoimmune hemolytic anemia
AustriaStudy of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
AustriaStudy of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer
AustriaStudy of Port Delivery System with ranibizumab given every 36 weeks in patients with neovascular age-related macular degeneration
AustriaStudy of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment
AustriaStudy of fosmanogepix compared to standard antifungal drugs for treating invasive mold infections in adults
AustriaStudy of Debio 4126, a new octreotide formulation, compared to placebo in patients with acromegaly who were previously treated with somatostatin analogs
AustriaStudy of Bleximenib, Venetoclax, and Azacitidine Treatment for Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
